Condition
Primary Bilary Cirrhosis (PBC)
Total Trials
2
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
Treatment Research
1 treatments under study, led by Observational No Intervention
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 2 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Not Yet Recruiting1
Recruiting1
Clinical Trials (2)
Research Network
Common Treatments
- Observational No Intervention1
Active Sponsors
- University Health Network, Toronto1
- University of Leipzig1
Top Investigators
University Health Network, Toronto General Hospital
University of Alberta
Related Conditions
- Autoimmune Hepatitis1
- Overlap Syndrome1